Anticancer properties of lamellarins

156Citations
Citations of this article
72Readers
Mendeley users who have this article in their library.

Abstract

In 1985 the first lamellarins were isolated from a small oceanic sea snail. Today, more than 50 lamellarins have been inventoried and numerous derivatives synthesized and tested as antiviral or anticancer agents. The lead compound in the family is lamellarin D, characterized as a potent inhibitor of both nuclear and mitochondrial topoisomerase I but also capable of directly interfering with mitochondria to trigger cancer cell death. The pharmacology and chemistry of lamellarins are discussed here and the mechanistic portrait of lamellarin D is detailed. Lamellarins frequently serve as a starting point in the design of anticancer compounds. Extensive efforts have been devoted to create novel structures as well as to improve synthetic methods, leading to lamellarins and related pyrrole-derived marine alkaloids.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Bailly, C. (2015, March 1). Anticancer properties of lamellarins. Marine Drugs. MDPI AG. https://doi.org/10.3390/md13031105

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 19

58%

Researcher 9

27%

Professor / Associate Prof. 5

15%

Readers' Discipline

Tooltip

Chemistry 24

65%

Agricultural and Biological Sciences 5

14%

Biochemistry, Genetics and Molecular Bi... 5

14%

Pharmacology, Toxicology and Pharmaceut... 3

8%

Article Metrics

Tooltip
Mentions
References: 1

Save time finding and organizing research with Mendeley

Sign up for free